Mizuho Boosts CVS Health Rating to Outperform Amid Stable Medicare Star Scores

Mizuho has upgraded CVS Healths rating to Outperform, citing stable Medicare Advantage Star Ratings from the Centers for Medicare & Medicaid Services, which signals a positive outlook amidst competitive pressures.

• Mizuho set a price target of $80.00 for CVS Health, affirming its Outperform rating following the release of 2026 Medicare Advantage Star Ratings by the Centers for Medicare & Medicaid Services.
• CVS Health maintained a consistent percentage of members in 4.0+ Star plans, aligning with Mizuhos expectations, while competitors like UnitedHealth Group and Humana showed variable results.
• The stability in CVS Healths Medicare Advantage plans comes as the Federal government of the United States continues to evaluate and adjust health insurance frameworks for 2026.